Skip to main content
SpringerLink
Log in
Book cover

Medikamentös induzierte neurologische und psychiatrische Störungen pp 231–249Cite as

Zerebelläre Ataxien

  • Chapter

  • 787 Accesses

This is a preview of subscription content, log in via an institution.

eBook
USD   19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Alvarez FG, Guntupalli KK (1995) Isoniazid overdose: four case reports and review of the literature. Intensive Care Med 21: 641–644

    Article  PubMed  CAS  Google Scholar 

  • Andersen KE (1981) Pharmacokinetics of nitroimidazoles. Spectrum of adverse reactions. Scand J Infect Dis (Suppl 26): 60–67

    Google Scholar 

  • Andersen NE, Lynch NM, O’Brien KP (1985) Disabling neurological complications of amiodarone. Aust N Z J Med 15: 300–304

    Google Scholar 

  • Apte SN, Langston JW (1983) Permanent neurological deficits due to lithium toxicity. Ann Neurol 13:453–455

    Article  PubMed  CAS  Google Scholar 

  • Arai A, Sato M, Hozumi I et al. (1997) Cerebellar ataxia and peripheral neuropathy due to chronic bromvaleryurea poisoning. Intern Med 36: 742–746

    PubMed  CAS  Google Scholar 

  • Bartels M, Hornung K, Schied HW (1989) Cerebellar side effects in treatment with antide-pressive agents. Psychiatr Prax 16: 109–112

    PubMed  CAS  Google Scholar 

  • Baulac M, Cavalcanti D, Semah E, Arzimanoglou A, Portal JJ (1998) Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Seizure 7: 55–62

    Article  PubMed  CAS  Google Scholar 

  • Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 13: 313–326

    Article  PubMed  CAS  Google Scholar 

  • Belli LS, De Carlis L, Romani F et al. (1993) Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant recipient. Transpl Int 6: 176–178

    Article  PubMed  CAS  Google Scholar 

  • Bendiksen A, Larsen LM (1998) Convulsions, ataxia and hallucinations following propofol. Acta Anaesthesiol Scand 42: 739–741

    PubMed  CAS  Google Scholar 

  • Berbel Garcia A, Latorre Ibarra A, Porta Etessam J, Martinez Salio A, Perez Martinez D, Siaz Diaz R, Toledo Heras M (2000) Protease inhibitor-induced carbamazepine toxicity. Clin Neuropharmacol 23: 216–218

    PubMed  CAS  Google Scholar 

  • Bikadoroff S (1987) Mental changes associated with tocainide, a new antiarrhythmic. Can J Psychiat 32: 219–221

    CAS  Google Scholar 

  • Botez MI, Attig E, Vezina JL (1988) Cerebellar atrophy in epileptic patients. Can J Neurol Sci 15: 299–303

    PubMed  CAS  Google Scholar 

  • Charness ME, Morady F, Scheinman MM (1984) Frequent neurologic toxicity associated with amiodarone therapy. Neurology 34: 669–671

    PubMed  CAS  Google Scholar 

  • Conners GP (1995) Piperazine neurotoxicity: worm wobble revisited. J Emerg Med 13: 341–343

    Article  PubMed  CAS  Google Scholar 

  • Couch LS, Groteluschen DL, Stewart JA, Mulkerin DL (2003) Capecitabine-related neurotoxicity presenting as trismus. Clin Colorectal Cancer 3: 121–123

    Article  PubMed  Google Scholar 

  • Dam M (1972) The density and ultrastructure of the Purkinje cells following diphenylhydantoin treatment in animals and man. Acta Neurol Scand 48(Suppl 49): 1–65

    Google Scholar 

  • Degner D, Grohmann R, Bliech S, Ruther E (2000) New antidepressant drugs. What side effects and interactions can be expected? MMW/Fortschr Med 142: 35–38, 40

    CAS  Google Scholar 

  • De Marcos FA, Ghizoni E, Kobayashi E, Li LM, Cendes F (2003) Cerebellar volume and long-term use of phenytoin. Seizure 12: 312–315

    PubMed  Google Scholar 

  • Floris-Moore MA, Amodio-Groton MI, Catalano MT (2003) Adverse reactions to trimethoprim/sulfamethoxazole in AIDS. Ann Pharmacother 37: 1810–1813

    Article  PubMed  Google Scholar 

  • Fujino Y, Tsuboi Y, Shimoju E, Takahashi M, Yamada T (2000) Progressive cerebellar atrophy following acute antidepressant intoxication. Rinsho Shinkeigaku 40: 1033–1037

    PubMed  CAS  Google Scholar 

  • Gerpen JA van (1997) Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS. Neurology 48: 537–538

    PubMed  Google Scholar 

  • Ghatak NR, Santoso RA, McKinney WM (1976) Cerebellar degeneration following long-term phenytoin therapy. Neurology 26: 818–830

    PubMed  CAS  Google Scholar 

  • Gijtenbeek JM, van der Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246: 339–346

    Article  PubMed  CAS  Google Scholar 

  • Gordon MF, Abrams RI, Rubin DB, Barr WB, Correa DD (1995) Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord 10: 220–222

    PubMed  CAS  Google Scholar 

  • Heaney CJ, Campeau NG, Lindell EP (2003) MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. Am J Neuroradiol 24: 1615–1617

    PubMed  Google Scholar 

  • Hilleman D, Miller MA, Parker R, Doering P, Pieper JA (1998) Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 18: 138S–145S

    PubMed  CAS  Google Scholar 

  • Hotson JR, Langston JW (1976) Disulfiram-induced encephalopathy. Arch Neurol 33:141–142

    PubMed  CAS  Google Scholar 

  • Hufnagel A (1998) Das neue Antikonvulsivum Tiagabin (Gabitril). Akt Neurol 25: 25–37

    Article  Google Scholar 

  • Iivanainen M, Viukari M, Helle EP (1977) Cerebellar atrophy in phenytoin-treated mentally retarded epileptics. Epilepsia 18: 375–386

    PubMed  CAS  Google Scholar 

  • Jain P, Reddy RB, Miscra A, Mukhopadhyay DK (1993) Isoniazid induced cerebellar ataxia. Natl Med J India 6: 149

    PubMed  CAS  Google Scholar 

  • Jungreis AC, Schaumburg HH (1993) Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology 43: 1265

    PubMed  CAS  Google Scholar 

  • Kälviäinen R (2001) Long-term safety of tiagabine. Epilepsia 42: 46–48

    PubMed  Google Scholar 

  • Karas BJ, Wilder BJ, Hammond EJ, Bauman AW (1982) Valproate tremors. Neurology 32: 428–432

    PubMed  CAS  Google Scholar 

  • Karp BI, Yang JC, Khorsand M, Wood R, Merigan TC (1996) Multiple cerebral lesions complicating therapy with interleucin-2. Neurology 47: 417–424

    PubMed  CAS  Google Scholar 

  • Kastrup O, Diener HC (2003) Nebenwirkungen medikamentöser Therapien in der Neurologie. In: Brandt T, Dichgans J, Diener HC (Hrsg) Therapie und Verlauf neurologischer Erkrankungen, 4. Aufl. Kohlhammer, Stuttgart, S 1453–1469

    Google Scholar 

  • Kawakami T, Takiyama Y, Yanaka I, Taguchi T, Tanaka Y, Nishizawa M, Nakano I (1998) Chronic bromvalerylurea intoxication: dystonic posture and cerebellar ataxia due to nonsteroidal anti-inflammatory drug abuse. Intern Med 37: 788–791

    PubMed  CAS  Google Scholar 

  • Kores B, Lader MH (1997) Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol 20: 283–299

    Article  PubMed  CAS  Google Scholar 

  • Kuruvilla T, Bharucha NE (1997) Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 38: 500–502

    Article  PubMed  CAS  Google Scholar 

  • Lang EJ, Davis SM (2002) Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels. J Clin Neurosci 9: 308–309

    Article  PubMed  Google Scholar 

  • Lautermann J, Dehne N, Schacht J, Jahnke K (2004) Aminoglycoside-and cisplatin-ototoxicity: from basic science to clinics. Laryngorhinootologie 83: 317–323

    PubMed  CAS  Google Scholar 

  • Lechlin F, Dijs B van der, Benaim M (1996) Benzodiazepines: tolerability in elderly patients. Psychother Psychosom 65: 171–182

    Google Scholar 

  • Lesnik PG, Ciesielski KT, Hart BL, Benzel EC, Sanders JA (1998) Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model. Arch Neurol 55:1561–1568

    Article  PubMed  CAS  Google Scholar 

  • Lewin PK, McGreal D (1993) Isoniazid toxicity with cerebellar ataxia in a child. CMAJ 148:49

    PubMed  CAS  Google Scholar 

  • Liebers M (1928) Über Kleinhimatrophien bei Epilepsie nach epileptischen Krampfanfällen. Z Neurol Psychiatr 113: 739–756

    Google Scholar 

  • Lindvall O, Nilsson (1984) Cerebellar atrophy following phenytoin intoxication. Ann Neurol 16: 258–260

    Article  PubMed  CAS  Google Scholar 

  • MacDonald NE (1993) Isoniazid toxicity with cerebellar ataxia in a child. CMAJ 148: 1108

    PubMed  CAS  Google Scholar 

  • Manolis AS, Deering TF, Cameron J, Estes NA (1990) Mexiletine: pharmacology and therapeutic use. Clin Cardiol 13: 349–359

    PubMed  CAS  Google Scholar 

  • Manto MU, Jacquy J (2002) Other cerebellotoxic agents. In: Manto MU, Pandolfo M (Hrsg) The cerebellum and its disorders. Cambridge University Press, Cambridge, pp 342–366

    Google Scholar 

  • Manto MU, Jacquy J, Hildebrand J (1996) Cerebellar ataxia in upper limbs triggered by addition of carbamazepine to lithium treatment. Acta Neurol Belg 96: 316–317

    PubMed  CAS  Google Scholar 

  • Marson AG, Kadir ZA, Hutton JL, Chadwick DW (1997) The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 38: 859–880

    Article  PubMed  CAS  Google Scholar 

  • Masur H, Elger CE, Ludolph AC, Galanski M (1989) Cerebellar atrophy following acute intoxication with phenytoin. Neurology 39: 432–433

    PubMed  CAS  Google Scholar 

  • McIain LW, Martin JT, Allen JH (1980) Cerebellar degeneration due to chronic phenytoin therapy. Ann Neurol 7: 18–23

    Google Scholar 

  • Merritt HH, Putnam TJ (1939) Sodium diphenyl hydantoinate in treatment of convulsive seizures. Toxic symptoms and their prevention. Arch Neurol Psychiatry 42:1053–1058

    Google Scholar 

  • Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B (1998) The side-effects of ciclosporine-A and Tacrolimus. Clin Nephrol 49: 356–363

    PubMed  CAS  Google Scholar 

  • Murray W, Macnair DR, Talbot MD (1978) Ataxia during perhexiline maleate therapy. Practitioner 221: 757–758

    PubMed  CAS  Google Scholar 

  • Ney GC, Lantos G, Barr WB, Schaul N (1994) Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. Arch Neurol 51: 767–771

    PubMed  CAS  Google Scholar 

  • Noyes R, DuPont RL, Pecknold JC, Rifkin et al. (1988) Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiat 45: 423–428

    PubMed  Google Scholar 

  • Odeh M, Seligmann H, Oliven A (2000) Propafenone-induced ataxia: report of three cases. Am J Med Sci 320: 151–153

    PubMed  CAS  Google Scholar 

  • Ohara S, Hayashi R, Momoi H, Miki J, Yanagisawa N (1998) Mexiletine in the treatment of spasmodic torticollis. Mov Dis 13: 934–940

    CAS  Google Scholar 

  • Onifer TM, Whisnant JP (1957) Cerebellar ataxia and neuronitis after exposure to DDT and lindane. Mayo Clin Proc 32: 67–72

    PubMed  CAS  Google Scholar 

  • Onofri M, Thomas A (1999) Acetazolamide-responsive periodic ataxia induced by amiodarone. Mov Dis 14: 379–381

    Google Scholar 

  • Patterson RH, Couchenour RL (1999) Trimethoprim-sulfamethoxazole-induced tremor in an immunocompetent patient. Pharmacotherapy 19: 1456–1458

    PubMed  CAS  Google Scholar 

  • Rapport RL, Shaw CM (1977) Phenytoin-related cerebellar degeneration without seizures. Ann Neurol 2: 437–439

    Article  PubMed  Google Scholar 

  • Reife R, Pledger G, Wu SC (2001) Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 41: 66–71

    Google Scholar 

  • Riehl JL, Brown WJ (1964) Acute cerebellar syndrome secondary to 5-fluorouracil therapy. Neurology 14:961–967

    PubMed  CAS  Google Scholar 

  • Sachdeo R, Beydoun A, Schachter S, Vazquez B, Schaul N, Mesenbrink P, Kramer L, D’souza J (2001) Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 57: 864–871

    PubMed  CAS  Google Scholar 

  • Salinsky MC, Levine RL, Aubuchon JP, Schutta HS (1983) Acute cerebellar dysfunction with high-dose Ara-C therapy. Cancer 51: 426–429

    PubMed  CAS  Google Scholar 

  • Schied HW, Bartels M (1983) Transitory cerebellar ataxia from high dosage combination thymoleptic therapy. Pharmacopsychiatrica 16: 64–67

    CAS  Google Scholar 

  • Schou M (1984) Long-lasting neurological sequelae after lithium intoxication. Acta Psychiat Scand 70: 594–602

    PubMed  CAS  Google Scholar 

  • Schmidt D, Elger CE (2004) How is oxcarbazepine different from carbamazepine? Nervenarzt 75: 153–160

    Article  PubMed  CAS  Google Scholar 

  • Schutz HJ, Busse O, Vuia O (1983) Polyneuropathy caused by disulfiram poisoning. Arch Psychiatr Nervenkr 233: 1–8

    PubMed  CAS  Google Scholar 

  • Selhorst JB, Kaufman B, Horwitz SJ (1972) Diphenylhydantoin-induced cerebellar degeneration. Arch Neurol 27: 453–455

    PubMed  CAS  Google Scholar 

  • Shroff R, Houston B (2002) Unusual cerebellar ataxia: “worm wobble” revisited. Arch Dis Child 87: 333–334

    Article  PubMed  CAS  Google Scholar 

  • Sisodiya SM, Sander JW, Patsalos PN (2002) Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction. Epilepsy Res 48: 217–219

    Article  PubMed  CAS  Google Scholar 

  • Specht U, May TW, Rohde M, Wagner V, Schmidt RC, Schütz M, Wolf P (1997) Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. Arch Neurol 54: 427–432

    PubMed  CAS  Google Scholar 

  • Spielmeyer W (1930) The anatomic substratum of the convulsive state. Arch Neurol Psychiat 23: 869–875

    Google Scholar 

  • Squier W, Hope PL, Lindenbaum RH (1990) Neocerebellar hypoplasia in a neonate following intra-uterine exposure to anticonvulsants. Dev Med Child Neurol 32: 737–742

    PubMed  CAS  Google Scholar 

  • Steinhoff BJ (2004) Nebenwirkungen der Antiepileptika. In: Fröscher W, Vassella F, Hufnagel A (Hrsg) Die Epilepsien. Schattauer, Stuttgart, S 564–602

    Google Scholar 

  • Steinhoff BJ, Herrendorf G, Bittermann HJ, Kurth C (1997) Isolated ataxia as an idiosyncratic side-effect under gabapentin. Seizure 6: 503–504

    Article  PubMed  CAS  Google Scholar 

  • Streib EW (1986) Successful treatment with tocainide of recessive generalized congenital myotonia. Ann Neurol 19: 501–504

    Article  PubMed  CAS  Google Scholar 

  • Symonds RP, Hogg RB, Bone I (1994) Paraneoplastic neurological syndromes associated with lymphomas. Leuk Lymphoma 15: 487–490

    Article  PubMed  CAS  Google Scholar 

  • Tartara A, Manni R, Galimberti CA, Mrini R, Mumford JP, Iudic A, Perruca E (1992) Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 86: 247–251

    Article  PubMed  CAS  Google Scholar 

  • Tauer U, Knoth R, Volk B (1998) Phenytoin alters Purkinje cell axon morphology and targeting in vitro. Acta Neuropathol 95: 583–591

    Article  PubMed  CAS  Google Scholar 

  • Timmann D, Kolb FP, Maschke M (2004) Motorische und kognitive Störungen bei zerebel-lären Erkrankungen. Akt Neurol 31: 170–179

    Google Scholar 

  • Timmann-Braun D, Diener HC (2000) Alcoholic cerebellar degeneration (including ataxias that are due to other toxic causes). In: Klockgether T (Hrsg) Handbook of cerebellar ataxia disorders. Marcel Dekker, New York, pp 571–605

    Google Scholar 

  • Tomson T (1984) Interdosage fluctuations in plasma carbamazepine concentrations determine intermittent side effects. Arch Neurol 41: 830–834

    PubMed  CAS  Google Scholar 

  • Tuxen MK, Hansen SW (1994) Complications of treatment. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 20: 191–214

    Article  PubMed  CAS  Google Scholar 

  • Utterback RA (1958) Parenchymatous cerebellar degeneration complicating diphenylhydantoin (Dilantin) therapy. Arch Neurol Psychiat 80: 180–181

    Google Scholar 

  • Utterback RA, Ojeman R, Malek J (1958) Parenchymatous cerebellar degeneration with Dilantin intoxication. J Neuropathol Exp Neurol 17: 516–519

    Google Scholar 

  • Valsamis MP, Mancall E (1973) Toxic cerebellar degeneration. Hum Pathol 4: 513–520

    PubMed  CAS  Google Scholar 

  • Volk B, Kirchgässer N, Detmar M (1986) Degeneration of granule cells following chronic phenytoin administration: an electron microscopic investigation of the mouse cerebellum. Exp Neurol 91: 60–70

    Article  PubMed  CAS  Google Scholar 

  • Wijdicks EF, Arendt C, Bazzell MC (2004) Postoperative ophthalmoplegia and ataxia due to carbamazepine toxicity facilitated by diltiazem. J Neuroophthalmol 24: 95

    PubMed  Google Scholar 

  • Wildemann B, Steinhoff BJ (2002) Epilepsien und Epilepsiesyndrome. In: Wildemann B, Fogel W, Grau A (Hrsg) Therapieleitfaden Neurologie. Kohlhammer, Stuttgart, S 377–400

    Google Scholar 

  • Wiley CC, Wiley JF (1998) Pediatric benzodiazepine ingestion resulting in hospitalization. J Toxicol Clin Toxicol 36: 227–231

    Article  PubMed  CAS  Google Scholar 

  • Winkelman MD, Hines JD (1983) Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Ann Neurol 14: 520–527

    Article  PubMed  CAS  Google Scholar 

  • Wizniter M, Packer RJ, Rorke LB, Meadows AT (1987) Cerebellar sclerosis in pediatric cancer patients. J Neurooncol 4: 353–360

    Article  PubMed  CAS  Google Scholar 

  • Woodruff BK, Wijdicks EF, Marshall WF (2002) Reversible metronidazole-induced lesions of the cerebellar dentate nuclei. N Engl J Med 346: 68–69

    Article  PubMed  Google Scholar 

  • Yasui N, Otani K, Kaneko S, Shimoyama R, Ohkubo T, Sugawara K (1997) Carbamazepine toxicity induced by clarithromycin coadministration in psychiatric patients. Int Clin Psychopharmacol 12:225–229

    PubMed  CAS  Google Scholar 

  • Yeshurun M, Marsot Dupuch K (2001) Acute cerebellar syndrome following intermediate-dose cytarabine. Br J Maematol 113: 846

    CAS  Google Scholar 

  • Young GB, Oppenheimer SR, Gordon BA et al. (1994) Ataxia in institutionalized patients with epilepsy. Can J Neurol Sci 21: 252–258

    PubMed  CAS  Google Scholar 

  • Zitelli BJ, Howrie DL, Altman H, Maroon TJ (1987) Erythromycin-induced drug interactions. An illustrative case and review of the literature. Clin Pediatr 26: 117–119

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik und Poliklinik, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen

    Prof. Dr. med. D. Timmann & Dr. rer. nat. S. Richter

Authors
  1. Prof. Dr. med. D. Timmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. rer. nat. S. Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Helios-Kliniken Schwerin, Wismarsche Straße 392-397, 19049, Schwerin

    Frank Block

  2. Gangelter Einrichtungen Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Brunchstraße 6, 52538, Gangelt

    Christian Prüter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Timmann, D., Richter, S. (2006). Zerebelläre Ataxien. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_13

Download citation

  • DOI: https://doi.org/10.1007/3-540-28604-7_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28590-8

  • Online ISBN: 978-3-540-28604-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation